Predictors of Non-Relapse Mortality Among Patients Treated with Sirolimus- Vs. Non- Sirolimus-Containing Immune Suppression for Graft-Versus-Host Disease Prevention Farhad Khimani, Erin Dean, Victoria Rizk, Jongphil Kim, PhD, Lu Chen, Taiga Nishihori, MD, Mohamed Kharfan-Dabaja, MD, Brian Betts, MD, Asmita Mishra, MD, Ernesto Ayala, MD, Frederick L. Locke, MD, Teresa Field, MD, PhD, Jose Leonel Ochoa-Bayona, MD, Lia Elena Perez, MD, Michael L. Nieder, MD, Melissa Alsina, MD, Hugo Fernandez, MD, Claudio Anasetti, MD, Joseph A. Pidala, MD, PhD Biology of Blood and Marrow Transplantation Volume 22, Issue 3, Pages S402-S403 (March 2016) DOI: 10.1016/j.bbmt.2015.11.930 Copyright © 2016 Terms and Conditions
Biology of Blood and Marrow Transplantation 2016 22, S402-S403DOI: (10 Biology of Blood and Marrow Transplantation 2016 22, S402-S403DOI: (10.1016/j.bbmt.2015.11.930) Copyright © 2016 Terms and Conditions
Biology of Blood and Marrow Transplantation 2016 22, S402-S403DOI: (10 Biology of Blood and Marrow Transplantation 2016 22, S402-S403DOI: (10.1016/j.bbmt.2015.11.930) Copyright © 2016 Terms and Conditions